Your session is about to expire
← Back to Search
VACT-CP Group for Chronic Pain
Study Summary
This trial will develop a virtual ACT intervention for chronic pain (VACT-CP) for Veterans, which will utilize a personalized, social interface to address pain-related distress and functional difficulties of chronic pain.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Waitlist Control Group
- Group 2: VACT-CP Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the objective of this research endeavor?
"The main measure used to gauge success of this trial is a Usability Survey at the 8-week Post-Intervention. Additionally, The Chronic pain Values Inventory (CPVI), Pain Numeric Rating Scale and The Chronic Pain Acceptance Questionnaire (CPAQ) will also be employed as secondary outcome metrics. CPVI consists of 6 importance ratings from 0 to 5 and corresponding 6 success ratings which are averaged together for a score ranging from 1 - 6; whereas, CPAQ has an Activity Engagement subscale with 11 items scaling up to 77 points, in addition to 9 items on the Pain Willingness scale that can reach"
How many participants can be involved in this research endeavor?
"Affirmative. According to clinicaltrials.gov, this experimental trial is currently enrolling participants since its inception on March 17th 2022 and last revised on May 2nd 2022. The study requires 40 volunteers that can be recruited from two different sites."
Are there any vacancies still available for potential participants of this research?
"Affirmative. Clinicaltrials.gov data suggests that this trial is presently recruiting participants, which began on March 17th 2022 and was last modified on May 2nd 2022. The study requires 40 patients to be enrolled at two separate sites."
Share this study with friends
Copy Link
Messenger